Skip to main content

Table 3 Multivariate adjusted associations between epidemiologic characteristics and CA125, CA15.3, and HE4 among controls postmenopausal at blood collection: EPICa

From: Correlates of circulating ovarian cancer early detection markers and their contribution to discrimination of early detection models: results from the EPIC cohort

 

CA125

CA15.3

HE4b

beta

p

beta

p

beta

p

Age at blood draw (continuous)

    

0.016

<0.0001

Duration of oral contraceptive use (continuous)

    

−0.007

0.009

Parity (continuous)c

0.030

0.03

  

−0.036

0.03

Hysterectomy

−0.053

0.34

    

Uniliateral oophorectomy

−0.104

0.18

    

Age at menopause (continuous)

0.019

0.0009

  

−0.015

0.03

Type of HT (E alone vs. never)

−0.120

0.17

    

Ovulatory cyclesc, d(continuous)

−0.0001

0.76

    

BMI (kg/m2;  continuous)

  

0.013

0.003

  

Smoking

      

 Former vs never

0.006

0.87

0.081

0.03

−0.003

0.95

 Current vs never

−0.164

<0.0001

−0.018

0.66

0.385

<0.0001

  1. a1 control missing CA125 and 8 missing CA153; b Restricted to 538 controls; cmodel was run once including parity and excluding ovulatory cycles, then run again excluding parity and including ovulatory cycles. With the exception of ovulatory cycles, the betas and p-values shown are for the model including parity; d time between menarche and menopause with time subtracted for oral contraceptive use, pregnancy and breastfeeding. Note: Italicized p values indicate statistically significant associations